Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4550

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-4550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Atorvastatin Calcium 10 mg tablets, film-coated, oral dosage form. The package contains 100 tablets. The label includes directions for usual dosage and storage instructions (20-25°C with excursions to 15-30°C). It is labeled RX only and repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer details for Camber Pharma, Inc. are also present.*

FDA Label Image

Atorvachemicalstructure (Atorvachemicalstructure)

Chemical structure of atorvastatin calcium trihydrate, illustrating its molecular components including phenyl rings, hydroxyl groups, and calcium ion association.*

FDA Label Image

Atorvafigure1 (Atorvafigure1)

A line graph showing cumulative incidence percentage over 3.5 years comparing Atorvastatin and Placebo. The solid line represents Atorvastatin, and the dashed line represents Placebo. The graph includes hazard ratio and p-value statistics at the bottom right.*

FDA Label Image

Atorvafigure2 (Atorvafigure2)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis represents years of follow-up up to 5 years, and the y-axis shows cumulative hazard percentage. Two lines indicate hazard rates, with Atorvastatin consistently lower than placebo, with a hazard ratio (HR) of 0.63 (0.48-0.83) and p-value 0.001.*

FDA Label Image

Atorvafigure3 (Atorvafigure3)

A line graph showing the percentage of subjects experiencing a major cardiovascular event over a 5-year period for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio (HR 0.78) with confidence intervals and a p-value (0.0002).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.